查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1647398

质子治疗市场评估，依产品类型、适应症、设定类型、最终用途、地区、机会和预测，2018 年至 2032 年

Proton Therapy Market Assessment, By Product Type, By Indications, By Setup Type, By End-user, By Region, Opportunities and Forecast, 2018-2032F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 225 Pages | 商品交期: 3-5个工作天内

价格

全球质子治疗市场预计将从 2024 年的 7.6834 亿美元增长到 2032 年的 14.2214 亿美元，在预测期内（2025-2032 年）的复合年增长率为 8.00%。美国国家癌症研究所估计，美国有 623,405 人患有转移性癌症，预计到 2025 年这一数字将上升到 693,453 人。因此，对晚期癌症的有效治疗的需求日益增加。与放射疗法不同，质子疗法的副作用较少。这是因为放射疗法会损害目标区域附近的组织，而质子疗法只针对癌细胞而不会损害健康细胞。质子疗法由于副作用较少而成为一种流行的治疗选择。因此，由于质子治疗非常有效且对健康组织的影响最小，其需求和价值可能会持续上升。

其他因素包括对副作用更少、有效率更高的治疗方法的需求不断增加、质子治疗中心的迅速扩张、铅笔束扫瞄等技术的发展以提高治疗效率、保险覆盖范围的扩大、政府在癌症控制方面的举措不断增多，以及癌症生物学研究的重要性日益增加，以便更好地瞭解肿瘤微环境并增加有效治疗的可用性。

全球质子治疗中心数量的不断增加，提高了治疗机会和治疗能力，也推动了市场的成长。随着紧凑、经济高效的质子治疗系统的普及，越来越多的医院和癌症治疗中心正在采用这种先进技术。 2024年5月，IBA（Ion Beam Applications S.A.）与康乃狄克州质子治疗中心（耶鲁纽黑文健康、哈特福德医疗保健和质子国际合作成立）签署了安装Proteus ONE质子治疗系统的合约。该协议是一份多年期维护合同，预计患者将于 2026 年春季接受治疗。该协议是一份多年期维护合同，预计患者将于 2026 年春季接受治疗。该协议旨在确保准时的治疗时间，同时减轻患者前往现场的负担。新兴市场的中心将提高人们的认识，帮助增强患者对质子治疗的信心，并满足全球对精准癌症治疗解决方案日益增长的需求。

目录

第 1 章 专案范围与定义

第 2 章 研究方法

第 3 章执行摘要

第 4 章2018 年至 2032 年全球质子治疗市场展望

  • 市场规模分析及预测
    • 按金额
    • 按数量
  • 市占率分析及预测
    • 依产品类型
      • 系统
      • 服务
    • 按适应症
      • 头颈癌
      • 中枢神经系统癌症
      • 摄护腺癌
      • 乳癌
      • 肺癌
      • 儿童癌症
      • 消化系统癌症
      • 其他
    • 依设定类型
      • 单间系统
      • 多房间系统
    • 依最终用途
      • 医院
      • 质子治疗中心
      • 癌症中心或研究机构
    • 按地区
      • 北美洲
      • 欧洲
      • 亚太地区
      • 南美洲
      • 中东和非洲
    • 按公司划分的市场占有率分析（前 5 名及其他 - 按价值计算，2024 年）
  • 2024 年市场地图分析
    • 依产品类型
    • 按适应症
    • 依设定类型
    • 依最终用途
    • 按地区

第 5 章2018 年至 2032 年北美质子治疗市场展望

  • 市场规模分析及预测
    • 按金额
    • 按数量
  • 市占率分析及预测
    • 依产品类型
      • 系统
      • 服务
    • 按适应症
      • 头颈癌
      • 中枢神经系统癌症
      • 摄护腺癌
      • 乳癌
      • 肺癌
      • 儿童癌症
      • 消化系统癌症
      • 其他
    • 依设定类型
      • 单间系统
      • 多房间系统
    • 依最终用途
      • 医院
      • 质子治疗中心
      • 癌症中心或研究机构
    • 国家占有率
      • 美国
      • 加拿大
      • 墨西哥
  • 国家市场评估
    • 2018 年至 2032 年美国质子治疗市场展望
      • 市场规模分析及预测
      • 市占率分析及预测
    • 加拿大
    • 墨西哥

所有市场区隔均提供各对地区与国家。

第 6 章2018 年至 2032 年欧洲质子治疗市场展望

  • 德国
  • 法国
  • 义大利
  • 英国
  • 俄罗斯
  • 荷兰
  • 西班牙
  • 波兰

第 7 章 2018-2032 年亚太质子治疗市场展望

  • 印度
  • 中国
  • 日本
  • 澳大利亚
  • 越南
  • 韩国
  • 印尼
  • 菲律宾

第 8 章 2018-2032 年南美洲质子治疗市场展望

  • 巴西
  • 阿根廷

第 9 章2018 年至 2032 年中东和非洲质子治疗市场展望

  • 沙乌地阿拉伯
  • 阿拉伯联合大公国
  • 南非
  • 以色列

第 10 章 需求与供给分析

第11章 进出口分析

第 12 章 价值链分析

第 13 章 波特五力分析

第 14 章 PESTLE 分析

第 15 章 定价分析

第 16 章 市场动态

  • 市场推动因素
  • 市场课题

第 17 章 市场趋势与发展

第 18 章 监理架构与创新

  • 创新
  • 监理机关核准

第 19 章：专利格局

第 20 章个案研究

第 21 章 竞争格局

  • 五大市场领导者的竞争矩阵
  • 前 5 家公司的 SWOT 分析
  • 市场前十大主要公司的状况
    • 日立股份有限公司
      • 公司简介
      • 主要管理团队
      • 产品与服务
      • 财务状况（与报告相同）
      • 主要市场重点与地理分布
      • 近期发展/合作/伙伴关係/合併与收购
    • Ion Beam Applications（IBA）SA
    • Mevion Medical Systems, Inc.
    • Toshiba Energy Systems &Solutions Corporation
    • Sumitomo Heavy Industries, Ltd.
    • Optivus Proton Therapy, Inc.
    • Varian Medical Systems, Inc.
    • Mitsubishi Electric Corporation
    • Provision Solutions, LLC
    • ProTom International, Inc.

上述公司不依市场占有率排序，并且可能会根据研究工作期间获得的资讯进行更改。

第 22 章 策略建议

第 23 章 关于研究公司/免责声明

Product Code: MX12689

Global proton therapy is projected to witness a CAGR of 8.00% during the forecast period 2025-2032, growing from USD 768.34 million in 2024 to USD 1422.14 million in 2032. The rising prevalence of cancer is promoting the growth of the market; the National Cancer Institute has stated that 623,405 people in the United States are living with metastatic cancer, and this is expected to rise to 693,453 by 2025. Therefore, there is a growing need for effective treatment for advanced-stage cancer. Unlike radiation therapy, proton therapy produces fewer side effects. This is because radiation therapy damages the tissues near the targeted area, while proton therapy only targets cancerous cells without damaging the normal cells. Proton therapy has fewer side effects and, hence, has gained popularity for treatment. Therefore, demand and value for proton therapy will keep rising because the treatment is quite effective and has a minimal impact on healthy tissues.

Other factors include higher demand for treatments that have a better effectiveness rate with fewer side effects, the rapid expansion of proton therapy centers, technological developments that enhance treatment efficiency, such as pencil beam scanning, increased insurance coverage, increasing government initiatives in cancer control, and the growing importance given to research on cancer biology to understand the tumor microenvironment better and boost the availability of effective treatments.

The growing number of proton therapy centers worldwide with improved access and capacity enhances market growth. As compact and cost-effective proton therapy systems are increasingly installed, more hospitals and cancer treatment facilities are adopting this advanced technology. In May 2024, IBA (Ion Beam Applications S.A.) signed a contract with Connecticut Proton Therapy Center (a Partnership with Yale New Haven Health, Hartford HealthCare, and Proton International) to install a Proteus ONE proton therapy system. The agreement is a multiyear maintenance deal, and patients are expected to receive treatment in spring 2026. The agreement is a multiyear maintenance deal, and patients are expected to receive treatment in spring 2026. It is designed to alleviate burdens associated with patients traveling to sites while being on time with treatments. Centers in emerging markets create an awareness that helps increase patients' confidence in proton therapy, hence catering to the growing global need for precision-based cancer treatment solutions.

Growing Government Initiatives Boost Market Demand

Proton therapy is becoming increasingly popular due to increasing government efforts to develop more advanced cancer treatment facilities and healthcare infrastructure. Governments worldwide are investing in advanced medical devices and technologies to improve cancer care, thereby driving the adoption of proton therapy. In July 2024, Romania's Ministry of Health invested USD 123.276 million (EUR 120 million) in a project to build the country's first proton therapy center, thereby improving its healthcare infrastructure. This center will offer advanced cancer treatment, minimizing patients' need to go abroad and boosting demand and market growth for proton therapy in Romania. Moreover, market growth is also bolstering as more people become aware of the advantages of proton therapy over traditional radiation therapy, which includes higher precision in targeting tumors and fewer side effects. Establishing specialized healthcare centers and public-private partnerships further improves access to this cutting-edge therapy. Also, favorable policies, research funding, and infrastructure updates in emerging nations are accelerating the establishment of proton therapy centers, meeting the rising demand for innovative cancer treatment solutions.

Rising Research Activities Support Market Expansion

The proton therapy market is rapidly growing, driven by increased research activities emphasizing its clinical advantages and diversifying its uses. A study in proton therapy presented in 2024 at the American Society of Clinical Oncology (ASCO) annual meeting highlighted proton therapy as a potential new standard-of-care treatment for controlling head and neck malignancies. This study found that proton therapy provides superior precision in targeting tumors while protecting healthy surrounding tissues, lowering side effects, and improving patient quality of life. Such research findings provide persuasive evidence of proton therapy's superiority over traditional radiation therapies, and this evidence fueled the interest of healthcare providers as well as researchers. Such research is driving major investments in proton therapy technologies and infrastructure. As more clinical data emerges, the growing acknowledgment of proton therapy's benefits speeds up its adoption, building a strong foundation for sustained growth in the worldwide cancer domain.

Single-Room Systems; the Fastest Growing Segment in the Market

The single-room proton therapy system segment is expected to grow significantly during the forecast period, owing to its cost-effectiveness, compact design, and rising need for easily accessible cancer treatment options. Single-room systems, as compared to multi-room systems, require less space and lesser initial investments, making them an appealing option for smaller healthcare facilities and growing markets. There has been a noticeable increase in the installation of single-room systems, especially for cancer treatment, which supports this trend. Many cancer centers are currently using these systems to accurately treat localized tumors while lowering infrastructure costs. Moreover, the compact design of these single-room systems also facilitates faster installation and operational readiness, which helps medical professionals to better handle increasing cancer loads. In June 2024, the MEVION S250-FIT Proton Therapy System, a compact single-room system, was installed at Carol G. Simon Cancer Center (at Morristown Medical Center, U.S.). This new system, which will be utilized for service in 2025, will improve radiation oncology treatments and accelerate the growth of the single-room systems segment. Because of its clinical effectiveness, affordability, and scalability, positioning single-room systems plays a crucial role in the market expansion of proton therapy.

North America Dominates the Global Proton Therapy Market Share

North America is currently dominating the proton therapy market and holds a significant share because of various key factors contributing to its solid position in the market. The region has a well-established healthcare system, with advanced equipment to integrate new technologies such as proton therapy. The geriatric population in the U.S. has increased, leading to higher cases of cancer, thereby increasing the demand for advanced therapies. These supportive reimbursement policies of the U.S. healthcare system have relieved the financial barrier for patients and practitioners in adopting proton therapy. Continued growth in the number of centers providing proton therapy across the United States is due to private investment and government programs. These centers provide increased access to high-precision cancer treatment. For instance, in September 2024, UC Regents approved the UCSF cancer treatment center, including a proton therapy center, research space, life sciences incubator, and clinics in San Francisco's Dogpatch Power Station. The UCSF Life Sciences Building will provide advanced cancer care and innovative research facilities. Moreover, awareness among healthcare professionals and patients about the benefits of proton therapy is increased, which adds to the region's dominant position in the global market.

Future Market Scenario (2025 - 2032F)

The proton therapy market is expected to see substantial growth in the coming years with advancements in technology, increasing investment, and an increased awareness level worldwide. Another reason for this growth is the growing developments in compact proton therapy centers that need less space and have lower costs than multi-room systems. This compact solution brings proton therapy to the forefront of smaller health facilities and new markets. Investment in private and public sectors drives innovation, resulting in more efficient and cost-effective systems and enhanced treatment options. In July 2024, Australia invested USD 721 million in the Queensland Cancer Centre, which is expected to open in 2028. The center will offer proton beam therapy and other advanced treatments that increase the precision of cancer treatment. This is expected to propel the growth of the proton therapy market. Moreover, expanding cancer care institutes also supports market growth. For instance, BayCare Cancer Institute will open a 'compact' proton therapy center in 2025. Advanced technology allows for acceleration in construction, as the machines do not take up as much space as traditional ones. This will fuel further market growth because proton therapy is easier to access and has a reduced cost.

Furthermore, with a growing incidence of cancer and a desire for more precise, minimally invasive treatments, the market continues to expand rapidly. Proton therapy is bound to be transformative in the treatment of cancer going forward as infrastructural development and further clinical evidence will establish its superiority.

Key Players Landscape and Outlook

Key market players in the proton therapy market are strengthening their position through continuous technological innovation, collaborations, and geographic expansion. For instance, they invest in compact, cost-effective systems and optimize treatment precision. Increasing partnerships with healthcare service providers and research organizations accelerate adoption and market growth.

In January 2025, IBA (Ion Beam Applications SA) signed a deal with AIG Hospitals under which the latter committed to spend USD 96 million (Rs 800 crore) for equipping a Proteus ONE Proton Therapy System. This sophisticated acquisition, involving DynamicARC technology, will elevate IBA as a market leader in proton therapy equipment and service supply. It emphasizes IBA's commitment to developing cancer treatment technology and extending its international reach in the healthcare market.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Proton Therapy Market Outlook, 2018-2032F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Product Type
      • 4.2.1.1. Systems
        • 4.2.1.1.1. Cyclotron
        • 4.2.1.1.2. Synchrotron
        • 4.2.1.1.3. Synchrocyclotron
      • 4.2.1.2. Services
    • 4.2.2. By Indications
      • 4.2.2.1. Head and Neck Cancer
      • 4.2.2.2. Central Nervous System Cancer
      • 4.2.2.3. Prostate Cancer
      • 4.2.2.4. Breast Cancer
      • 4.2.2.5. Lung Cancer
      • 4.2.2.6. Pediatric Cancer
      • 4.2.2.7. Gastrointestinal Cancer
      • 4.2.2.8. Others
    • 4.2.3. By Setup Type
      • 4.2.3.1. Single-Room Systems
      • 4.2.3.2. Multi-Room Systems
    • 4.2.4. By End-user
      • 4.2.4.1. Hospitals
      • 4.2.4.2. Proton Therapy Centers
      • 4.2.4.3. Cancer Centers or Institutes
    • 4.2.5. By Region
      • 4.2.5.1. North America
      • 4.2.5.2. Europe
      • 4.2.5.3. Asia-Pacific
      • 4.2.5.4. South America
      • 4.2.5.5. Middle East and Africa
    • 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
  • 4.3. Market Map Analysis, 2024
    • 4.3.1. By Product Type
    • 4.3.2. By Indications
    • 4.3.3. By Setup Type
    • 4.3.4. By End-user
    • 4.3.5. By Region

5. North America Proton Therapy Market Outlook, 2018-2032F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
    • 5.1.2. By Volume
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. Product Type
      • 5.2.1.1. Systems
        • 5.2.1.1.1. Cyclotron
        • 5.2.1.1.2. Synchrotron
        • 5.2.1.1.3. Synchrocyclotron
      • 5.2.1.2. Services
    • 5.2.2. By Indications
      • 5.2.2.1. Head and Neck Cancer
      • 5.2.2.2. Central Nervous System Cancer
      • 5.2.2.3. Prostate Cancer
      • 5.2.2.4. Breast Cancer
      • 5.2.2.5. Lung Cancer
      • 5.2.2.6. Pediatric Cancer
      • 5.2.2.7. Gastrointestinal Cancer
      • 5.2.2.8. Others
    • 5.2.3. By Setup Type
      • 5.2.3.1. Single-Room Systems
      • 5.2.3.2. Multi-Room Systems
    • 5.2.4. By End-user
      • 5.2.4.1. Hospitals
      • 5.2.4.2. Proton Therapy Centers
      • 5.2.4.3. Cancer Centers or Institutes
    • 5.2.5. By Country Share
      • 5.2.5.1. United States
      • 5.2.5.2. Canada
      • 5.2.5.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States Proton Therapy Market Outlook, 2018-2032F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
        • 5.3.1.1.2. By Volume
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. Product Type
          • 5.3.1.2.1.1. Systems
          • 5.3.1.2.1.1.1. Cyclotron
          • 5.3.1.2.1.1.2. Synchrotron
          • 5.3.1.2.1.1.3. Synchrocyclotron
          • 5.3.1.2.1.2. Services
        • 5.3.1.2.2. By Indications
          • 5.3.1.2.2.1. Head and Neck Cancer
          • 5.3.1.2.2.2. Central Nervous System Cancer
          • 5.3.1.2.2.3. Prostate Cancer
          • 5.3.1.2.2.4. Breast Cancer
          • 5.3.1.2.2.5. Lung Cancer
          • 5.3.1.2.2.6. Pediatric Cancer
          • 5.3.1.2.2.7. Gastrointestinal Cancer
          • 5.3.1.2.2.8. Others
        • 5.3.1.2.3. By Setup Type
          • 5.3.1.2.3.1. Single-Room Systems
          • 5.3.1.2.3.2. Multi-Room Systems
        • 5.3.1.2.4. By End-user
          • 5.3.1.2.4.1. Hospitals
          • 5.3.1.2.4.2. Proton Therapy Centers
          • 5.3.1.2.4.3. Cancer Centers or Institutes
    • 5.3.2. Canada
    • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Proton Therapy Market Outlook, 2018-2032F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Poland

7. Asia-Pacific Proton Therapy Market Outlook, 2018-2032F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. South Korea
  • 7.7. Indonesia
  • 7.8. Philippines

8. South America Proton Therapy Market Outlook, 2018-2032F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa Proton Therapy Market Outlook, 2018-2032F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa
  • 9.4. Israel

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

  • 16.1. Market Drivers
  • 16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

  • 18.1. Innovations
  • 18.2. Regulatory Approvals

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

  • 21.1. Competition Matrix of Top 5 Market Leaders
  • 21.2. SWOT Analysis for Top 5 Players
  • 21.3. Key Players Landscape for Top 10 Market Players
    • 21.3.1. Hitachi, Ltd.
      • 21.3.1.1. Company Details
      • 21.3.1.2. Key Management Personnel
      • 21.3.1.3. Products and Services
      • 21.3.1.4. Financials (As Reported)
      • 21.3.1.5. Key Market Focus and Geographical Presence
      • 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 21.3.2. Ion Beam Applications (IBA) SA
    • 21.3.3. Mevion Medical Systems, Inc.
    • 21.3.4. Toshiba Energy Systems & Solutions Corporation
    • 21.3.5. Sumitomo Heavy Industries, Ltd.
    • 21.3.6. Optivus Proton Therapy, Inc.
    • 21.3.7. Varian Medical Systems, Inc.
    • 21.3.8. Mitsubishi Electric Corporation
    • 21.3.9. Provision Solutions, LLC
    • 21.3.10. ProTom International, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

22. Strategic Recommendations

23. About Us and Disclaimer

List of Tables

  • Table 1. Competition Matrix of Top 5 Market Leaders
  • Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Proton Therapy Market, By Value, In USD Million, 2018-2032F
  • Figure 2.Global Proton Therapy Market, By Volume, In Million Units, 2018-2032F
  • Figure 3.Global Proton Therapy Market Share (%), By Product Type, 2018-2032F
  • Figure 4.Global Proton Therapy Market Share (%), By Indications, 2018-2032F
  • Figure 5.Global Proton Therapy Market Share (%), By Setup Type, 2018-2032F
  • Figure 6.Global Proton Therapy Market Share (%), By End-user, 2018-2032F
  • Figure 7.Global Proton Therapy Market Share (%), By Region, 2018-2032F
  • Figure 8.North America Proton Therapy Market, By Value, In USD Million, 2018-2032F
  • Figure 9.North America Proton Therapy Market, By Volume, In Million Units, 2018-2032F
  • Figure 10.North America Proton Therapy Market Share (%), By Product Type, 2018-2032F
  • Figure 11.North America Proton Therapy Market Share (%), By Indications, 2018-2032F
  • Figure 12.North America Proton Therapy Market Share (%), By Setup Type, 2018-2032F
  • Figure 13.North America Proton Therapy Market Share (%), By End-user, 2018-2032F
  • Figure 14.North America Proton Therapy Market Share (%), By Country, 2018-2032F
  • Figure 15.United States Proton Therapy Market, By Value, In USD Million, 2018-2032F
  • Figure 16.United States Proton Therapy Market, By Volume, In Million Units, 2018-2032F
  • Figure 17.United States Proton Therapy Market Share (%), By Product Type, 2018-2032F
  • Figure 18.United States Proton Therapy Market Share (%), By Indications, 2018-2032F
  • Figure 19.United States Proton Therapy Market Share (%), By Setup Type, 2018-2032F
  • Figure 20.United States Proton Therapy Market Share (%), By End-user, 2018-2032F
  • Figure 21.Canada Proton Therapy Market, By Value, In USD Million, 2018-2032F
  • Figure 22.Canada Proton Therapy Market, By Volume, In Million Units, 2018-2032F
  • Figure 23.Canada Proton Therapy Market Share (%), By Product Type, 2018-2032F
  • Figure 24.Canada Proton Therapy Market Share (%), By Indications, 2018-2032F
  • Figure 25.Canada Proton Therapy Market Share (%), By Setup Type, 2018-2032F
  • Figure 26.Canada Proton Therapy Market Share (%), By End-user, 2018-2032F
  • Figure 27.Mexico Proton Therapy Market, By Value, In USD Million, 2018-2032F
  • Figure 28.Mexico Proton Therapy Market, By Volume, In Million Units, 2018-2032F
  • Figure 29.Mexico Proton Therapy Market Share (%), By Product Type, 2018-2032F
  • Figure 30.Mexico Proton Therapy Market Share (%), By Indications, 2018-2032F
  • Figure 31.Mexico Proton Therapy Market Share (%), By Setup Type, 2018-2032F
  • Figure 32.Mexico Proton Therapy Market Share (%), By End-user, 2018-2032F
  • Figure 33.Europe Proton Therapy Market, By Value, In USD Million, 2018-2032F
  • Figure 34.Europe Proton Therapy Market, By Volume, In Million Units, 2018-2032F
  • Figure 35.Europe Proton Therapy Market Share (%), By Product Type, 2018-2032F
  • Figure 36.Europe Proton Therapy Market Share (%), By Indications, 2018-2032F
  • Figure 37.Europe Proton Therapy Market Share (%), By Setup Type, 2018-2032F
  • Figure 38.Europe Proton Therapy Market Share (%), By End-user, 2018-2032F
  • Figure 39.Europe Proton Therapy Market Share (%), By Country, 2018-2032F
  • Figure 40.Germany Proton Therapy Market, By Value, In USD Million, 2018-2032F
  • Figure 41.Germany Proton Therapy Market, By Volume, In Million Units, 2018-2032F
  • Figure 42.Germany Proton Therapy Market Share (%), By Product Type, 2018-2032F
  • Figure 43.Germany Proton Therapy Market Share (%), By Indications, 2018-2032F
  • Figure 44.Germany Proton Therapy Market Share (%), By Setup Type, 2018-2032F
  • Figure 45.Germany Proton Therapy Market Share (%), By End-user, 2018-2032F
  • Figure 46.France Proton Therapy Market, By Value, In USD Million, 2018-2032F
  • Figure 47.France Proton Therapy Market, By Volume, In Million Units, 2018-2032F
  • Figure 48.France Proton Therapy Market Share (%), By Product Type, 2018-2032F
  • Figure 49.France Proton Therapy Market Share (%), By Indications, 2018-2032F
  • Figure 50.France Proton Therapy Market Share (%), By Setup Type, 2018-2032F
  • Figure 51.France Proton Therapy Market Share (%), By End-user, 2018-2032F
  • Figure 52.Italy Proton Therapy Market, By Value, In USD Million, 2018-2032F
  • Figure 53.Italy Proton Therapy Market, By Volume, In Million Units, 2018-2032F
  • Figure 54.Italy Proton Therapy Market Share (%), By Product Type, 2018-2032F
  • Figure 55.Italy Proton Therapy Market Share (%), By Indications, 2018-2032F
  • Figure 56.Italy Proton Therapy Market Share (%), By Setup Type, 2018-2032F
  • Figure 57.Italy Proton Therapy Market Share (%), By End-user, 2018-2032F
  • Figure 58.United Kingdom Proton Therapy Market, By Value, In USD Million, 2018-2032F
  • Figure 59.United Kingdom Proton Therapy Market, By Volume, In Million Units, 2018-2032F
  • Figure 60.United Kingdom Proton Therapy Market Share (%), By Product Type, 2018-2032F
  • Figure 61.United Kingdom Proton Therapy Market Share (%), By Indications, 2018-2032F
  • Figure 62.United Kingdom Proton Therapy Market Share (%), By Setup Type, 2018-2032F
  • Figure 63.United Kingdom Proton Therapy Market Share (%), By End-user, 2018-2032F
  • Figure 64.Russia Proton Therapy Market, By Value, In USD Million, 2018-2032F
  • Figure 65.Russia Proton Therapy Market, By Volume, In Million Units, 2018-2032F
  • Figure 66.Russia Proton Therapy Market Share (%), By Product Type, 2018-2032F
  • Figure 67.Russia Proton Therapy Market Share (%), By Indications, 2018-2032F
  • Figure 68.Russia Proton Therapy Market Share (%), By Setup Type, 2018-2032F
  • Figure 69.Russia Proton Therapy Market Share (%), By End-user, 2018-2032F
  • Figure 70.Netherlands Proton Therapy Market, By Value, In USD Million, 2018-2032F
  • Figure 71.Netherlands Proton Therapy Market, By Volume, In Million Units, 2018-2032F
  • Figure 72.Netherlands Proton Therapy Market Share (%), By Product Type, 2018-2032F
  • Figure 73.Netherlands Proton Therapy Market Share (%), By Indications, 2018-2032F
  • Figure 74.Netherlands Proton Therapy Market Share (%), By Setup Type, 2018-2032F
  • Figure 75.Netherlands Proton Therapy Market Share (%), By End-user, 2018-2032F
  • Figure 76.Spain Proton Therapy Market, By Value, In USD Million, 2018-2032F
  • Figure 77.Spain Proton Therapy Market, By Volume, In Million Units, 2018-2032F
  • Figure 78.Spain Proton Therapy Market Share (%), By Product Type, 2018-2032F
  • Figure 79.Spain Proton Therapy Market Share (%), By Indications, 2018-2032F
  • Figure 80.Spain Proton Therapy Market Share (%), By Setup Type, 2018-2032F
  • Figure 81.Spain Proton Therapy Market Share (%), By End-user, 2018-2032F
  • Figure 82.Turkey Proton Therapy Market, By Value, In USD Million, 2018-2032F
  • Figure 83.Turkey Proton Therapy Market, By Volume, In Million Units, 2018-2032F
  • Figure 84.Turkey Proton Therapy Market Share (%), By Product Type, 2018-2032F
  • Figure 85.Turkey Proton Therapy Market Share (%), By Indications, 2018-2032F
  • Figure 86.Turkey Proton Therapy Market Share (%), By Setup Type, 2018-2032F
  • Figure 87.Turkey Proton Therapy Market Share (%), By End-user, 2018-2032F
  • Figure 88.Poland Proton Therapy Market, By Value, In USD Million, 2018-2032F
  • Figure 89.Poland Proton Therapy Market, By Volume, In Million Units, 2018-2032F
  • Figure 90.Poland Proton Therapy Market Share (%), By Product Type, 2018-2032F
  • Figure 91.Poland Proton Therapy Market Share (%), By Indications, 2018-2032F
  • Figure 92.Poland Proton Therapy Market Share (%), By Setup Type, 2018-2032F
  • Figure 93.Poland Proton Therapy Market Share (%), By End-user, 2018-2032F
  • Figure 94.South America Proton Therapy Market, By Value, In USD Million, 2018-2032F
  • Figure 95.South America Proton Therapy Market, By Volume, In Million Units, 2018-2032F
  • Figure 96.South America Proton Therapy Market Share (%), By Product Type, 2018-2032F
  • Figure 97.South America Proton Therapy Market Share (%), By Indications, 2018-2032F
  • Figure 98.South America Proton Therapy Market Share (%), By Setup Type, 2018-2032F
  • Figure 99.South America Proton Therapy Market Share (%), By End-user, 2018-2032F
  • Figure 100.South America Proton Therapy Market Share (%), By Country, 2018-2032F
  • Figure 101.Brazil Proton Therapy Market, By Value, In USD Million, 2018-2032F
  • Figure 102.Brazil Proton Therapy Market, By Volume, In Million Units, 2018-2032F
  • Figure 103.Brazil Proton Therapy Market Share (%), By Product Type, 2018-2032F
  • Figure 104.Brazil Proton Therapy Market Share (%), By Indications, 2018-2032F
  • Figure 105.Brazil Proton Therapy Market Share (%), By Setup Type, 2018-2032F
  • Figure 106.Brazil Proton Therapy Market Share (%), By End-user, 2018-2032F
  • Figure 107.Argentina Proton Therapy Market, By Value, In USD Million, 2018-2032F
  • Figure 108.Argentina Proton Therapy Market, By Volume, In Million Units, 2018-2032F
  • Figure 109.Argentina Proton Therapy Market Share (%), By Product Type, 2018-2032F
  • Figure 110.Argentina Proton Therapy Market Share (%), By Indications, 2018-2032F
  • Figure 111.Argentina Proton Therapy Market Share (%), By Setup Type, 2018-2032F
  • Figure 112.Argentina Proton Therapy Market Share (%), By End-user, 2018-2032F
  • Figure 113.Asia-Pacific Proton Therapy Market, By Value, In USD Million, 2018-2032F
  • Figure 114.Asia-Pacific Proton Therapy Market, By Volume, In Million Units, 2018-2032F
  • Figure 115.Asia-Pacific Proton Therapy Market Share (%), By Product Type, 2018-2032F
  • Figure 116.Asia-Pacific Proton Therapy Market Share (%), By Indications, 2018-2032F
  • Figure 117.Asia-Pacific Proton Therapy Market Share (%), By Setup Type, 2018-2032F
  • Figure 118.Asia-Pacific Proton Therapy Market Share (%), By End-user, 2018-2032F
  • Figure 119.Asia-Pacific Proton Therapy Market Share (%), By Country, 2018-2032F
  • Figure 120.India Proton Therapy Market, By Value, In USD Million, 2018-2032F
  • Figure 121.India Proton Therapy Market, By Volume, In Million Units, 2018-2032F
  • Figure 122.India Proton Therapy Market Share (%), By Product Type, 2018-2032F
  • Figure 123.India Proton Therapy Market Share (%), By Indications, 2018-2032F
  • Figure 124.India Proton Therapy Market Share (%), By Setup Type, 2018-2032F
  • Figure 125.India Proton Therapy Market Share (%), By End-user, 2018-2032F
  • Figure 126.China Proton Therapy Market, By Value, In USD Million, 2018-2032F
  • Figure 127.China Proton Therapy Market, By Volume, In Million Units, 2018-2032F
  • Figure 128.China Proton Therapy Market Share (%), By Product Type, 2018-2032F
  • Figure 129.China Proton Therapy Market Share (%), By Indications, 2018-2032F
  • Figure 130.China Proton Therapy Market Share (%), By Setup Type, 2018-2032F
  • Figure 131.China Proton Therapy Market Share (%), By End-user, 2018-2032F
  • Figure 132.Japan Proton Therapy Market, By Value, In USD Million, 2018-2032F
  • Figure 133.Japan Proton Therapy Market, By Volume, In Million Units, 2018-2032F
  • Figure 134.Japan Proton Therapy Market Share (%), By Product Type, 2018-2032F
  • Figure 135.Japan Proton Therapy Market Share (%), By Indications, 2018-2032F
  • Figure 136.Japan Proton Therapy Market Share (%), By Setup Type, 2018-2032F
  • Figure 137.Japan Proton Therapy Market Share (%), By End-user, 2018-2032F
  • Figure 138.Australia Proton Therapy Market, By Value, In USD Million, 2018-2032F
  • Figure 139.Australia Proton Therapy Market, By Volume, In Million Units, 2018-2032F
  • Figure 140.Australia Proton Therapy Market Share (%), By Product Type, 2018-2032F
  • Figure 141.Australia Proton Therapy Market Share (%), By Indications, 2018-2032F
  • Figure 142.Australia Proton Therapy Market Share (%), By Setup Type, 2018-2032F
  • Figure 143.Australia Proton Therapy Market Share (%), By End-user, 2018-2032F
  • Figure 144.Vietnam Proton Therapy Market, By Value, In USD Million, 2018-2032F
  • Figure 145.Vietnam Proton Therapy Market, By Volume, In Million Units, 2018-2032F
  • Figure 146.Vietnam Proton Therapy Market Share (%), By Product Type, 2018-2032F
  • Figure 147.Vietnam Proton Therapy Market Share (%), By Indications, 2018-2032F
  • Figure 148.Vietnam Proton Therapy Market Share (%), By Setup Type, 2018-2032F
  • Figure 149.Vietnam Proton Therapy Market Share (%), By End-user, 2018-2032F
  • Figure 150.South Korea Proton Therapy Market, By Value, In USD Million, 2018-2032F
  • Figure 151.South Korea Proton Therapy Market, By Volume, In Million Units, 2018-2032F
  • Figure 152.South Korea Proton Therapy Market Share (%), By Product Type, 2018-2032F
  • Figure 153.South Korea Proton Therapy Market Share (%), By Indications, 2018-2032F
  • Figure 154.South Korea Proton Therapy Market Share (%), By Setup Type, 2018-2032F
  • Figure 155.South Korea Proton Therapy Market Share (%), By End-user, 2018-2032F
  • Figure 156.Indonesia Proton Therapy Market, By Value, In USD Million, 2018-2032F
  • Figure 157.Indonesia Proton Therapy Market, By Volume, In Million Units, 2018-2032F
  • Figure 158.Indonesia Proton Therapy Market Share (%), By Product Type, 2018-2032F
  • Figure 159.Indonesia Proton Therapy Market Share (%), By Indications, 2018-2032F
  • Figure 160.Indonesia Proton Therapy Market Share (%), By Setup Type, 2018-2032F
  • Figure 161.Indonesia Proton Therapy Market Share (%), By End-user, 2018-2032F
  • Figure 162.Philippines Proton Therapy Market, By Value, In USD Million, 2018-2032F
  • Figure 163.Philippines Proton Therapy Market, By Volume, In Million Units, 2018-2032F
  • Figure 164.Philippines Proton Therapy Market Share (%), By Product Type, 2018-2032F
  • Figure 165.Philippines Proton Therapy Market Share (%), By Indications, 2018-2032F
  • Figure 166.Philippines Proton Therapy Market Share (%), By Setup Type, 2018-2032F
  • Figure 167.Philippines Proton Therapy Market Share (%), By End-user, 2018-2032F
  • Figure 168.Middle East & Africa Proton Therapy Market, By Value, In USD Million, 2018-2032F
  • Figure 169.Middle East & Africa Proton Therapy Market, By Volume, In Million Units, 2018-2032F
  • Figure 170.Middle East & Africa Proton Therapy Market Share (%), By Product Type, 2018-2032F
  • Figure 171.Middle East & Africa Proton Therapy Market Share (%), By Indications, 2018-2032F
  • Figure 172.Middle East & Africa Proton Therapy Market Share (%), By Setup Type, 2018-2032F
  • Figure 173.Middle East & Africa Proton Therapy Market Share (%), By End-user, 2018-2032F
  • Figure 174.Middle East & Africa Proton Therapy Market Share (%), By Country, 2018-2032F
  • Figure 175.Saudi Arabia Proton Therapy Market, By Value, In USD Million, 2018-2032F
  • Figure 176.Saudi Arabia Proton Therapy Market, By Volume, In Million Units, 2018-2032F
  • Figure 177.Saudi Arabia Proton Therapy Market Share (%), By Product Type, 2018-2032F
  • Figure 178.Saudi Arabia Proton Therapy Market Share (%), By Indications, 2018-2032F
  • Figure 179.Saudi Arabia Proton Therapy Market Share (%), By Setup Type, 2018-2032F
  • Figure 180.Saudi Arabia Proton Therapy Market Share (%), By End-user, 2018-2032F
  • Figure 181.UAE Proton Therapy Market, By Value, In USD Million, 2018-2032F
  • Figure 182.UAE Proton Therapy Market, By Volume, In Million Units, 2018-2032F
  • Figure 183.UAE Proton Therapy Market Share (%), By Product Type, 2018-2032F
  • Figure 184.UAE Proton Therapy Market Share (%), By Indications, 2018-2032F
  • Figure 185.UAE Proton Therapy Market Share (%), By Setup Type, 2018-2032F
  • Figure 186.UAE Proton Therapy Market Share (%), By End-user, 2018-2032F
  • Figure 187.South Africa Proton Therapy Market, By Value, In USD Million, 2018-2032F
  • Figure 188.South Africa Proton Therapy Market, By Volume, In Million Units, 2018-2032F
  • Figure 189.South Africa Proton Therapy Market Share (%), By Product Type, 2018-2032F
  • Figure 190.South Africa Proton Therapy Market Share (%), By Indications, 2018-2032F
  • Figure 191.South Africa Proton Therapy Market Share (%), By Setup Type, 2018-2032F
  • Figure 192.South Africa Proton Therapy Market Share (%), By End-user, 2018-2032F
  • Figure 193.By Product Type Map-Market Size (USD Million) & Growth Rate (%), 2024
  • Figure 194.By Indications Map-Market Size (USD Million) & Growth Rate (%), 2024
  • Figure 195.By Setup Type Map-Market Size (USD Million) & Growth Rate (%), 2024
  • Figure 196.By End-user Map-Market Size (USD Million) & Growth Rate (%), 2024
  • Figure 197.By Region Map-Market Size (USD Million) & Growth Rate (%), 2024